Paysign officer reports 15K option, stock awards
Paysign, Inc. officer Matthew Baker reports existing stock options and restricted stock awards with no new buy or sell transactions.
Rhea-AI Filing Summary
Paysign, Inc. (PAYS) reported initial insider holdings for officer Matthew Baker, President, Patient Affordability, in a Form 3. The filing lists a non-qualified stock option to purchase 15,000 shares of common stock at an exercise price of $3.87 per share, expiring on March 23, 2030, plus prior restricted stock awards with multi‑year vesting schedules. No new purchases or sales are reported, only existing equity awards and positions.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Turner Matthew Baker
Role
PRES., PATIENT AFFORDABILITY
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Non-Qualified Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (Right to Buy) — 15,000 contracts (Direct);
Common Stock — 236,667 shares (Direct)
Footnotes (3)
- F1. On January 6, 2023, the reporting person received a restricted stock award of 200,000 shares of common stock, vesting 1/5 on each of January 31, 2024 and each anniversary of such date thereafter. The remaining 120,000 unvested shares will vest in equal installments on January 31, 2026, January 31, 2027, and January 31, 2028, and the shares will be delivered to the reporting person on each such vesting date.
- F2. On May 7, 2025, the reporting person received a restricted stock award of 116,667 shares of common stock, vesting 1/3 on each of May 22, 2026, May 26, 2027, and May 24, 2028. The shares will vest in equal installments on May 22, 2026, May 26, 2027, and May 24, 2028, and the shares will be delivered to the reporting person on each such vesting date.
- F3. On March 23, 2020, the reporting person received an award of 15,000 stock options, vesting 1/5 on each anniversary of the grant date.
Key Figures
Non-qualified stock options: 15,000 options
Option exercise price: $3.87 per share
Option expiration: March 23, 2030
+2 more
5 metrics
Non-qualified stock options
15,000 options
Award received March 23, 2020, reported as a holding on Form 3
Option exercise price
$3.87 per share
Exercise price for 15,000 non-qualified stock options expiring March 23, 2030
Option expiration
March 23, 2030
Expiration date for 15,000 non-qualified stock options
Restricted stock award 2023
200,000 shares
Restricted stock award granted January 6, 2023, vesting over five years
Restricted stock award 2025
116,667 shares
Restricted stock award granted May 7, 2025, vesting in three equal installments
Key Terms
Non-Qualified Stock Option, restricted stock award, vesting, exercise price
4 terms
Non-Qualified Stock Option financial
"securityTitle: Non-Qualified Stock Option (Right to Buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
restricted stock award financial
"the reporting person received a restricted stock award of 200,000 shares"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
vesting financial
"vesting 1/5 on each of January 31, 2024 and each anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"exercisePrice: "3.8700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider holdings does Paysign (PAYS) officer Matthew Baker report on this Form 3?
He reports a non-qualified stock option for 15,000 shares of Paysign common stock at an exercise price of $3.87 per share, expiring March 23, 2030, along with previously granted restricted stock awards that vest over several years.
What stock option award for Paysign (PAYS) does the Form 3 disclose?
It discloses a 15,000‑share non-qualified stock option on Paysign common stock, with an exercise price of $3.87 per share and an expiration date of March 23, 2030. The option vests in five equal annual installments from the March 23, 2020 grant date.
What restricted stock awards in Paysign (PAYS) are described for Matthew Baker?
He received a 200,000‑share restricted stock award on January 6, 2023, vesting 1/5 annually each January 31 from 2024 to 2028, and a 116,667‑share restricted stock award on May 7, 2025, vesting in three equal installments in 2026, 2027, and 2028.
What is Matthew Baker’s role at Paysign (PAYS) according to this filing?
The Form 3 identifies Matthew Baker as an officer of Paysign with the title President, Patient Affordability. The filing reports his equity‑based holdings and awards in that capacity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
